Top

Published in:

01-06-2004

Incidence of Transitional Cell Carcinoma of the Bladder and Arsenic Exposure in New Hampshire

Authors: Margaret R. Karagas, Tor D. Tosteson, J. Steven Morris, Eugene Demidenko, Leila A. Mott, John Heaney, Alan Schned

Published in: Cancer Causes & Control | Issue 5/2004

Title: Incidence of Transitional Cell Carcinoma of the Bladder and Arsenic Exposure in New Hampshire
Authors: Margaret R. Karagas
Tor D. Tosteson
J. Steven Morris
Eugene Demidenko
Leila A. Mott
John Heaney
Alan Schned
Publication date: 01-06-2004
Publisher: Kluwer Academic Publishers
Published in: Cancer Causes & Control / Issue 5/2004
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1023/B:CACO.0000036452.55199.a3

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 5/2004

Occupational Exposure to Vinyl Chloride, Acrylonitrile and Styrene and Lung Cancer Risk (Europe)

Occupational Exposure to Carbon Black and Risk of Cancer

Physical Activity, Body Size, and Estrogen Metabolism in Women

Differences in Testis Cancer Survival by Race and Ethnicity: A Population-Based Study, 1973–1999 (United States)

Stem Cells and Prenatal Origin of Breast Cancer

Better Knowledge Translation for Effective Cancer Control: A Priority for Action

Keynote webinar | Spotlight on antibody–drug conjugates in cancer